Skip to main content
Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc. — Investor Relations & Filings

Ticker · SANA ISIN · US7995661045 US Manufacturing
Filings indexed 362 across all filing types
Latest filing 2025-03-14 Capital/Financing Update
Country US United States of America
Listing US SANA

About Sana Biotechnology, Inc.

https://sana.com/

Sana Biotechnology, Inc. is a company that develops engineered cells as medicines to address the underlying causes of disease. Its core strategy involves two primary platforms: in vivo therapies designed to repair and control genes within a patient's existing cells, and ex vivo therapies that replace missing or damaged cells with new, functional ones. The company utilizes proprietary technologies, such as engineered fusogen proteins, for the targeted delivery of therapeutics. Sana's pipeline is focused on advancing drug candidates for a range of diseases, including diabetes, B-cell cancers, and B-cell related autoimmune disorders.

Recent filings

Filing Released Lang Actions
POSASR
Capital/Financing Update Classification · 100% confidence The document is a Post-Effective Amendment No. 1 to a Form S-3 Registration Statement filed with the SEC by Sana Biotechnology, Inc. It is a regulatory filing related to securities registration under the Securities Act of 1933. The text includes a prospectus for offering up to $350 million in securities, describing the types of securities and the terms of the offering. There is no financial statement or detailed financial performance data presented; rather, it is a legal and regulatory document related to capital raising and securities registration. This type of document fits the category of Capital/Financing Update (CAP) because it updates on company fundraising and capital structure changes through a registration statement and prospectus for securities offerings.
2025-03-14 English
PRIMARY DOCUMENT
Director's Dealing
2025-03-11 English
PRIMARY DOCUMENT
Director's Dealing
2025-03-11 English
PRIMARY DOCUMENT
Director's Dealing
2025-03-11 English
PRIMARY DOCUMENT
Director's Dealing
2025-03-04 English
Regulatory Filings 2025
Regulatory Filings
2025-02-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.